Atlas Trials

Reversal of the Anti-platelet Effects of Ticagrelor

Clinical trial NCT02383771 · COMPLETED

Trial details

NCT number
NCT02383771
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Coronary Artery Disease
Start date
2015-03-01
Primary completion
2016-11-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.